In short
Immunoglobulin G4-related disease is a complex immune condition that can silently damage multiple organs before patients even realize something is wrong, often masquerading as cancer or other serious illnesses.
Key points
- IgG4-related disease can silently damage organs for months or years before causing noticeable symptoms, making early awareness crucial
- Unlike most autoimmune diseases, IgG4-RD affects men more frequently than women and tends to be more severe in males
- The disease often masquerades as cancer, with tumor-like masses that lead to initial misdiagnosis and sometimes unnecessary surgeries
- IgG4-RD can affect virtually any organ, but most commonly involves the pancreas, kidneys, eye structures, salivary glands, and retroperitoneal tissues
- The exact cause remains unknown, though genetic factors, bacterial infections, and molecular mimicry are thought to play roles
- Characteristic microscopic features include dense immune cell infiltration, storiform (cartwheel-like) fibrosis, and obliterative phlebitis (vein inflammation)
- Most patients have multiple organs involved at diagnosis, with anywhere from two to six organs commonly affected simultaneously
- The disease almost never causes fever, which helps distinguish it from infectious conditions with similar presentations
Risk Factors for Developing IgG4-RD
Given that the precise cause of IgG4-related disease is not fully understood, identifying specific risk factors remains challenging. However, certain characteristics appear to be associated with a higher likelihood of developing the condition.
Being male is one of the most clear risk factors for IgG4-RD. Men are not only more likely to develop the disease but also tend to experience more severe manifestations with multiple organ involvement. The reasons for this gender difference are not yet fully understood, but it represents an important epidemiological pattern that distinguishes IgG4-RD from many other autoimmune conditions.
Age also plays a role, with middle-aged and older adults being more commonly affected. While the disease can occur at any age, the typical patient is diagnosed around age 60. This suggests that factors associated with aging may contribute to disease development or that the disease requires many years to develop before becoming clinically apparent.
Having a genetic predisposition is thought to be another risk factor, though specific genes associated with IgG4-RD have not been definitively identified. Family studies and genetic research are ongoing to better understand the hereditary components of this disease.
Symptoms and How They Affect Patients
The symptoms of IgG4-related disease vary widely depending on which organs are affected, making this a particularly unpredictable condition for patients to live with. Some patients describe feeling as though they must "spin the wheel" each morning to see what symptoms they will face that day. This unpredictability adds a significant emotional and practical burden to living with IgG4-RD.
Many patients experience common symptoms that are not specific to any particular organ. These include swollen lymph nodes, unexplained weight loss, and persistent fatigue. Weight loss is particularly common when multiple organs are involved or when the pancreas does not produce enough digestive enzymes. Importantly, IgG4-RD almost never causes fever, which helps distinguish it from infectious conditions.
When IgG4-RD affects the pancreas and bile ducts, patients may develop painless jaundice, which causes the skin and eyes to turn yellow. This occurs when swelling of the pancreas blocks the flow of bile from the liver to the digestive tract. Some people develop acute inflammation of the pancreas, called pancreatitis, which causes severe abdominal pain and nausea. Others develop chronic pancreatitis over time, leading to symptoms such as gas, feeling full quickly, diarrhea, poor nutrition, weight loss, and even diabetes.
Disease affecting the retroperitoneal tissues (at the back of the abdomen) may not cause any symptoms at first, or it may cause flank or back pain. The fibrous tissue that develops can compress the tubes that carry urine from the kidneys to the bladder, called ureters, blocking urine flow and potentially damaging the kidneys. When the walls of the aorta (the main blood vessel from the heart) are affected, this can lead to a dangerous bulging called an aortic aneurysm.
The salivary and lacrimal (tear) glands are frequently affected in IgG4-RD. When this occurs, patients notice painless swelling on one or both sides of the face, below the chin, or over the outer portion of the upper eyelids. Despite this swelling, dry mouth and dry eyes are actually uncommon in IgG4-RD, which helps distinguish it from similar conditions like Sjögren disease.
When IgG4-RD affects the orbits (the structures surrounding the eyes), particularly the muscles that control eye movement, patients may develop bulging eyes, swelling and pain around the eyes, double vision, or pain when moving the eyes. This type of involvement is among the most frequent manifestations of IgG4-RD, observed in almost 20% of cases.
Lung involvement may cause no symptoms at all, or patients may experience cough, shortness of breath, or sharp chest pain when breathing in. The pain often results from inflammation of the pleura, which are the thin layers of tissue separating the lungs from the chest wall.
Additional symptoms that can occur include headaches, dysfunction of the cranial nerves (the nerves that emerge directly from the brain), inflammation in the thyroid gland, sinus complications, runny nose, sneezing, swelling in various areas of the body, difficulty breathing, and enlarged kidneys.
Pathophysiology: How IgG4-RD Changes the Body
The pathophysiology of IgG4-related disease involves a series of abnormal immune responses that lead to characteristic changes in affected organs. Understanding these changes helps explain both how the disease damages the body and why certain treatments are effective.
The hallmark of IgG4-RD is the accumulation of immune cells, particularly lymphocytes and plasma cells, in affected tissues. Plasma cells are specialized white blood cells that produce antibodies. In IgG4-RD, there is a dense infiltration of these cells, many of which produce IgG4 antibodies. This infiltration is polyclonal, meaning it involves many different types of immune cells rather than a single clone, which helps distinguish IgG4-RD from cancerous conditions like lymphoma.
A key feature seen under the microscope is storiform fibrosis, which is a specific pattern of scar tissue formation that looks like a cartwheel or storiform (mat-like) pattern. This distinctive scarring pattern is one of the characteristic findings that helps pathologists diagnose IgG4-RD. The fibrosis results from expansion of the extracellular matrix, which is the network of proteins and other molecules that provide structural support to tissues.
Another important pathological feature is obliterative phlebitis, which involves inflammation and eventual destruction of veins within affected tissues. The inflammation causes the vein walls to become thickened and the vessel opening to become narrowed or completely closed off. This feature, along with storiform fibrosis, is seen in all affected tissues except bone marrow and lymph nodes, making these two sites less ideal for obtaining diagnostic tissue samples.
The disease also frequently involves eosinophils, a type of white blood cell normally involved in allergic reactions and fighting parasites. The variable presence of eosinophils in affected tissues is another characteristic feature of IgG4-RD. Many patients have elevated numbers of eosinophils in their blood, a condition called eosinophilia.
B cells, particularly those expressing the CD19 marker on their surface, play a central role in the disease process. These cells accumulate in affected tissues and are thought to drive inflammation both directly through the production of inflammatory proteins and indirectly by activating other immune cells called T cells. The lesions in IgG4-RD are rich in these CD19-positive B cells, which helps explain why treatments targeting B cells are often effective.
Elevated levels of IgG4 in the blood are frequent in patients with IgG4-RD, though not universal. Some patients have normal IgG4 levels despite having active disease. Additionally, elevated IgG4 levels can occur in other conditions, so the blood test alone is not sufficient for diagnosis. The disease also commonly causes polyclonal hypergammaglobulinemia, which means there is a generalized increase in all types of antibodies in the blood, not just IgG4.
The clinical manifestations of IgG4-RD—the tumor-like masses and organ enlargement—result from this dense tissue infiltration by immune cells and the expansion of scar tissue. Over time, affected organs can become filled with fibrosis, and if left untreated, this damage can become permanent. This is why early diagnosis and treatment are so important in preventing irreversible organ dysfunction.
